SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-033284
Filing Date
2024-07-29
Accepted
2024-07-29 16:13:19
Documents
60
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cort-20240630.htm   iXBRL 10-Q 889946
2 EX-10.1 cort63024ex101tenthamendme.htm EX-10.1 29273
3 EX-31.1 cort63024ex311.htm EX-31.1 9427
4 EX-31.2 cort63024ex312.htm EX-31.2 9513
5 EX-32.1 cort63024ex321.htm EX-32.1 5088
6 EX-32.2 cort63024ex322.htm EX-32.2 5014
12 image_0.jpg GRAPHIC 218889
  Complete submission text file 0001628280-24-033284.txt   4794282

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cort-20240630.xsd EX-101.SCH 30515
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cort-20240630_cal.xml EX-101.CAL 68770
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cort-20240630_def.xml EX-101.DEF 96096
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cort-20240630_lab.xml EX-101.LAB 449595
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cort-20240630_pre.xml EX-101.PRE 283778
62 EXTRACTED XBRL INSTANCE DOCUMENT cort-20240630_htm.xml XML 480865
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50679 | Film No.: 241152494
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)